 ÏÊ»¨( 219)  ¼¦µ°( 0)
|
% z8 i4 m- X4 e" D/ @: r
% ^/ t" q/ w4 P8 G2 [- {
" y: h* z$ d, @´ó¼ÒºÃ£¬# @ Q* u! Y/ Y$ ^9 l) P
" _" B3 {4 h, a. B. G»¶Ó¹âÁÙ½¡¿µÓªÑøÕ¾É̳ǡ£ÎÒÊǽ¡¿µÓªÑøÕ¾µÄ°æÖ÷¡£ÎÒ±ÏÒµÓÚU Of A ÓªÑøÏµ¡£Ä¿Ç°¾ÓªÓªÑø²úÆ·¡£ÎÒËù¾ÓªµÄÓªÑø²úÆ·±£Öʱ£Á¿¡£¶øÇÒÔÚͬÑùµÄÆ·ÅÆÀÎÒ±£Ö¤¼ÛÇ®×îµÍ¡£ ¿µ¼ÓÃÀ²úÆ·ÊÇÎÒĿǰ¾ÓªµÄÖ÷Òª²úÆ·Ö®Ò»¡£ÎªÁËÄúµÄ·½±ã£¬ËùÓвúÆ·µÄÏêϸÇé¿öºÍ¼ÛÇ®¿ÉÒÔµã»÷ÕâÀïÕÒµ½
: k0 G* O+ X" J! s: m, I[url]http://www.edmontonchina.ca/forumdisplay.php?fid=911 e% C4 v6 Y" b. O5 j( M
) \* _3 E7 s: u9 o. i% v: r' v! Q¶©¹º×Éѯ£º£¨780£©669-6586²úÆ·  780-249-1365
# J `2 Y5 k: Q& T' V% B* }' kEmail£º c.health@hotmail.com- e# L* v1 `% R9 c4 X+ j/ n
" Z4 Y- H8 u. J% E- k( ~. s* I
¿µ¼ÓÃÀ²úÆ·¼ò½é£º- X9 Z! M0 l. J5 P' Q- h. t
4 m* o1 x# Y. w/ h* T+ m. R¼ÓÃÀ¿ÆÑÐÖÆÒ©ÓÐÏÞ¹«Ë¾Î»ì¶×ÔÈ»×ÊÔ´·á¸»µÄ¼ÓÄô󰲴óÂÔÊ¡£¬Ç±ÐÄÑÐÖÆÌìȻҩÁƽ¡¿µ®bÆ·¡£ÎÒÃǵÄ×î´óÐÄÔ¸Êǽ«ÓÅÖÊÌìȻֲÎï»òº£ÑóÉúÎᆱ»ª£¬½áºÏ×ÔÈ»Éú»îµÄ½¡¿µÀíÄîÍÆ½é¸øËùÓмÒÍ¥£¬ ÁîÄãºÍ¼ÒÈËÊܵ½´¿×ÔÈ»µÄ±£»¤£¬×à³öÇáËɽ¡¿µÔÏÀÖ¡£
8 x% v3 ?& k7 r* l- z3 j+ B! K" G# o! c3 `2 h5 z$ g/ K
¼ÓÃÀ¿ÆÑÐÖÆÒ©ÊǼÓÄôó±¾ÍÁ¾ß¹æÄ£ºÍʵÁ¦µÄÖÆÒ©¹«Ë¾¡£ÎÒÃǵÄÖ÷ÒªÒµÎñ°üÀ¨ÓÅÖʱ£½¡Æ·µÄÉú®b¡¢ÁãÊÛ¡¢Åú·¢£¬¸ü ‘´Óʸ߼¶±£½¡Æ·Éú®bµÄ³§¼ÒºÍ¸öÈËÌṩ¿É¿¿ÖÜÈ«µÄ¼Ó¹¤·þÎñ (OEM)¡£×Ô³ÉÁ¢ÒÁʼ£¬¼ÓÃÀ¿ÆÑÐ ²»¶ÏͶ·Å´óÁ¿×ÊÔ´Ñо¿ÌìÈ»½¡¿µÆ·¡£Ê®¶àÄêǰÒѳɹ¦½«ÌìÈ»º£±ªÓÍ¡¢ÉÈýÎÄÓãÓÍÔÓÍת»¯Îª¶àÖÖ±£½¡¹¦Ð§£¬ÈÝÒ×ÎüÊյĽ¡¿µ®bÆ·¡£ÆäUNCLE BILL Æ·ÅÆµÄÌìÈ»º£±ªÓÍ£¬ÉÓãÓÍ£¬ÂÑÁ×Ö¬µÈÌìÈ»®bÆ·Ê®¶àÄêÀ´Ò»Ö±±¸ÊÜÏû·ÑÕßÐÅÀµ£¬ÊÇ´ó¼Ò×ÔÓúÍÀ¡ÔùÇ×ÓѵÄÊ×Ñ¡ºÍÖ¸¶¨®bÆ·¡£
! K3 N w6 r- }) D1 k# K9 H8 Z. G0 q1 z( h, F* J( i* y
¶þÊ®ÔØ ¾Óª£¬ ¶þÊ®ÔØ³ÏÐÅ£¬ Ò»Èç¼ÈÍù. ¸ß¿Æ¼¼Í¶ÈëºÍ³¤¾QͶ×ʳɾÍÁ˼ÓÃÀ¿ÆÑÐÖÆÒ© ÔÚ½¡¿µ®bÆ·Òµ½çµÄÇ̳þµØÎ»£¬ÊµÁ¦²»ÈÝÖÃÒÉ¡£Ê±ÖÁ½ñÈÕ, ¼ÓÃÀ¿ÆÑÐÒÑ·¢Õ¹ ‘Ò»¼äÓÐʵÁ¦ºÍ¹æÄ£µÄÖÆÒ©¹«Ë¾¡£¼ÓÃÀµÄ¼¼ÊõÍÅÒ²ÈÕÒæ×³´ó£¬³ýÍøÂÞ±¾µØÒ½Ò©Ïµ¾«Ó¢Í⣬¸üÖØ½ðͶ×ÊÉ豸¾«Á¼µÄÒ©Æ·¼ìÑéʵÑéÊÒ£¬ ¶ÔÿÅú®bÆ·½øÐÐ Standard Operation Procedure (SOP)¼ì²â£¬½¨Á¢ÖÊÁ¿×·×Ù»ØÊÕϵͳ£¬ ¾ø¶Ô·ûºÏ¼ÓÄôóÎÀÉú²¿Ò©Îï¼à¹ÜÒªÇó, Æ·ÖÊ ‘Òµ½çÖ®¹Ú¡£ 3 }8 p% X) R [9 B l, B/ T5 H
( k' `: k6 U/ {¼ÓÃÀ¿ÆÑÐÖÆÒ©´´Á¢ºÇ»¤ÉíÐĵġ°¿µ¼ÓÃÀ¡±£¬¡°±êÊ塱һϵÁб£½¡¾«Æ·£¬ ÁÆÐ§ÏÔÖø£¬ÉîÊÜÓüÒÐÅÀµ¡£¼ÓÃÀ¿ÆÑÐÊôÏÂËùÓЮbÆ·¾ùÒÑÉ걨¼ÓÄôóÎÀÉú²¿£¬ÊÇ×îÖµµÃÐÅÀµµÄÌìÈ»±£½¡Æ·Éú®b³§¼Ò¡¢ÖøÃû½¡¿µ®bÆ·¶À¼Ò´úÀíºÍÅú·¢ÉÌ¡£
* N6 g/ H, n6 G1 U4 E( y8 l& T, J9 q0 z1 b% ?
¼ÓÃÀ¿ÆÑÐÉèÓжàÌõÏȽøµÄÉú®bÏߣ¬´ÓÖÆÔìµ½°ü×°¸÷ÖÖÉú®b³ÌÐò£¬¾ùÓɵçÄÔ¿ØÖÆ£¬²¢ÓµÓÐÉ豸ÍêÉÆµÄʵÑéÊÒ£¬¶ÔËùÓвÄÖʼ°ÖÆ³ÉÆ·½øÐÐÑϸñ²âÊÔ£¬·¢»Ó¿ÆÑ§¹ÜÀíµÄ³¬×¿Ð§ÄÜ¡£¼ÓÃÀµÄרҵÍŶӼá³ÖÒÔÆ·ÖÊΪ±¾£¬Á¦ÕéÍêÃÀ£¬²»¶ÏÇó½øºÍ´´Ð¡£
K5 C( _7 y% v+ K. G1 L) s5 q) T# M" K
¼ÓÃÀ¿ÆÑÐÓµÓÐÉ豸ÍêÉÆµÄʵÑéÊÒ£¬ ÎÒÃǵÄרҵ¼¼ÊõÔ±¶Ô¸÷ÖÖÔÁϺÍÖÆ³ÉÆ·½øÐзÖÎö£¬ È·±£ÔÁϸßЧÐÔ£¬²¢Ñϸñ²âÊÔÿÅú²úÆ·µÄÖÊÁ¿ºÍ°²È«ÐÔ¡£¼ÓÃÀ¿ÆÑÐÖÆÒ©Ëù²ÉÓÃÔ²ÄÁÏ£¬ ÖÆÔì¹ý³ÌºÍ³ÉÖÊÁ¿¾ù·ûºÏ«ÃÀ¹úÒ©µä» * (US Pharmacopoeia (USP))±ê×¼£¬²¿·ÖÔÁϺͮbÆ·ÉõÖÁ³¬¹ý´Ë±ê×¼¡£ # z: x7 w3 f3 a9 O
8 e! z( F& i. n$ E+ Z1 L* ]' J- E¼ÓÃÀ¿ÆÑÐÖÆÒ©µÄרҵ¾«Ó¢ÓÐÀ´×Ô±±ÃÀÖøÃû´óѧҽҩϵµÄ˶ʿºÍ ²©Ê¿£¬ ¼ÈÓÐÀ´×ÔÖйúÌìȻҩÎïÓë·ÂÉúÒ©Îï¹ú¼ÒÖØµãʵÑéÊÒ£¬»¹Óб±ÃÀÖÆÒ©ÐÐÒµ¾Ñé·á¸»µÄ¼¼Ê¦¡£ËûÃǶÔÌìÈ»®bÆ·µÄ¹¦Ð§ºÍÒ©ÀíÌØÐÔÓÐÉîÇÐÁ˽⡣¼ÓÃÀ¿ÆÑÐÖÆÒ©ÒѲ¼À³¿Ë´óѧ£¬ POLECNECTARÂ̷佺¹«Ë¾µÈ½øÐпÆÑкÏ×÷£¬²»¶Ï¸ÄÁ¼Ñз¢²úÆ·£¬ÎñÇó¸øÓè¹Ë¿Í×î¼ÑÆ·ÖÊ¡£
! m# ~6 t% u9 w- u: z. g3 O5 C: h
$ [. z5 z; _' G( a, N[ ±¾Ìû×îºóÓÉ ½¡¿µÓªÑøÕ¾ ÓÚ 2008-11-17 12:54 ±à¼ ]
6 a& M( h1 `9 P, D; M& C; i6 K5 w7 Q( Agmp.gif (9.82 KB, ÏÂÔØ´ÎÊý: 36)
+ `6 f! a& R& JGMO Approval
: X1 D. l9 s6 a3 a3 Z1 E/ q. I! `- M: C0 k$ y
site_lis.gif (14.48 KB, ÏÂÔØ´ÎÊý: 16)4 ?" c- ^5 f) n1 x0 \) r$ X$ i1 B
Canadian Licence
- R+ n( J, S6 R4 C& O6 R4 `+ h! u% @) k' z
|
|